-
A Blockbuster Drug, an Innovative Business Model and New Treatments Could Fuel Growth in the Biotech Industry
For investors who have long viewed biotechnology stocks as one of the best sources of long-term growth, new, potential breakthroughs could make the sector even more compelling. Senior Biotechnology Equity Research Analyst Salim Syed looks at three key developments that could help propel the sector for years to come.
-
A Shot in the Arm: COVID-19 Vaccines and Their Impact on the Pharmaceutical Sector
The COVID-19 pandemic has had a significant impact on the pharmaceutical sector, with companies pouring huge amounts of money and resources into treatments and vaccines. Dr. Vamil Divan shares his insights on the direct impacts.
-
Why Biotech is Poised for Continued Strength
In the race for a COVID-19 vaccine and amidst uncertain economic times, biotech is holding its own. Read more about the forces shaping the sector’s strength from Jason Fertig and Alex Lim.
-
A 2019 Healthcare Market Recap and 2020 Forecast by Mizuho Americas
Mizuho Equity Capital Markets' Mariano Gault gives us a rundown of the healthcare sector in 2019, and why he expects its positive momentum to continue.
-
Managed Care Investors Must Manage the Political Tradewinds
While the fundamentals of the industry look good, Managed Care isn’t immune to the political rhetoric of the day. Equity Analyst Ann Hynes helps us understand the intersection of healthcare stocks and politics.
-
Dry Eye on the Rise
There's been little improvement in treatment for dry eye disease over the past 20 years, but biotech analyst Difei Yang says new therapies are showing promise.
-
Equity Research Analyst Mara Goldstein on the Evolving Immuno-Oncology Sector
With scientific breakthroughs in genomics, antibody discovery, and cell and gene therapies, oncology is expected to attract a bigger R&D spend globally than ever before.
-
The History of Cancer Care
From hopeless to hyper-targeted, Salim Syed walks us through the evolution of cancer treatments— from early surgery in ancient times to the exciting prospects for immunotherapy, targeting tell-tale neoantigen proteins that identify cancer cells.
-
Time for a Checkup? Acute Care Booms with the Baby Boomers
The baby boomer generation is aging and it's impacting the healthcare market - acute care, in particular. Healthcare Services Analyst Ann Hynes helps us understand why.